Caxton

Latest statistics and disclosures from Caxton Corp's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Caxton consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Caxton Corp

Caxton Corp holds 9 positions in its portfolio as reported in the September 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Savara (SVRA) 47.6 $13M -33% 3.3M 3.78
 View chart
Xeris Pharmaceuticals (XERS) 39.9 $11M 5.6M 1.86
 View chart
Rezolute Com New (RZLT) 6.6 $1.7M 1.3M 1.32
 View chart
Molecular Templates Com New (MTEM) 3.3 $865k NEW 137k 6.32
 View chart
Apogee Therapeutics (APGE) 1.0 $266k NEW 13k 21.30
 View chart
Compass Therapeutics (CMPX) 0.6 $171k +99% 87k 1.97
 View chart
Aclaris Therapeutics (ACRS) 0.5 $133k NEW 20k 6.85
 View chart
Allakos (ALLK) 0.4 $112k +178% 49k 2.27
 View chart
Elevation Oncology (ELEV) 0.1 $15k 22k 0.66
 View chart

Past Filings by Caxton Corp

SEC 13F filings are viewable for Caxton Corp going back to 2013

View all past filings